UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051551
Receipt number R000058819
Scientific Title Effect of hyperbaric oxygen therapy on skin flap and graft-analysis by near-infrared time-resolved spectroscopy
Date of disclosure of the study information 2023/07/25
Last modified on 2024/01/09 16:10:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of hyperbaric oxygen therapy on skin flap and graft-analysis by near-infrared time-resolved spectroscopy

Acronym

Objective effect of hyperbaric oxygen therapy on skin flap and graft

Scientific Title

Effect of hyperbaric oxygen therapy on skin flap and graft-analysis by near-infrared time-resolved spectroscopy

Scientific Title:Acronym

Objective effect of hyperbaric oxygen therapy on skin flap and graft

Region

Japan


Condition

Condition

skin flap and skin graft

Classification by specialty

Anesthesiology Plastic surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To observe the changes in tissue oxygenation and tissue hemoglobin concentration measured by near-infrared time-resolved spectroscope before and after the hyperbaric oxygen therapy on skin flap and graft.
To observe chronological changes of these indices.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Acute changes in tissue oxygenation and tissue hemoglobin concentration measured by near-infrared time-resolved spectroscope before and after the hyperbaric oxygen therapy on skin flap and graft

Key secondary outcomes

chronological changes of tissue oxygenation and tissue hemoglobin concentration in continuing of hyperbaric oxygen therapy.
Evaluation of factors which may affect the effect of hyperbaric oxygen therapy.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients who consent to this study after the sufficient explanation

Key exclusion criteria

The patients whom a research director judges to be inappropriate as a study subject

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Yuji
Middle name
Last name Morimoto

Organization

Hokkaido University Hospital

Division name

Anesthesiology

Zip code

0608648

Address

N14 W5, Kita-ku, Sapporo

TEL

011-716-1161

Email

morim2@med.hokudai.ac.jp


Public contact

Name of contact person

1st name Yuji
Middle name
Last name Morimoto

Organization

Hokkaido University Hospital

Division name

Anesthesiology

Zip code

0608648

Address

N14 W5, Kita-ku, Sapporo

TEL

011-716-1161

Homepage URL


Email

morim2@med.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido University Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hokkaido University Hospital Division of Clinical Research Administraion

Address

N14 W5, Kita-ku, Sapporo

Tel

011-706-7636

Email

crjimu@huhp.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 07 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 06 Month 06 Day

Date of IRB

2023 Year 06 Month 29 Day

Anticipated trial start date

2023 Year 08 Month 01 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Prospective observational study
Study period:until 2025.12.31
Patients with skin flap or skin graft
Observational items:background, laboratory data, vital signs and tissue oxygenation and hemoglobin concentration


Management information

Registered date

2023 Year 07 Month 07 Day

Last modified on

2024 Year 01 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058819


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name